ELENA REYNA: Open Payments
NPI 1700433125 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,006 in 74 payments from 26 companies in 2025. Trend: 2023 $233 · 2024 $1,372 · 2025 $2,006
Food & beverage: $1,729Education: $277
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $286 |
| Astellas Pharma US Inc | 7 | $221 |
| Merck Sharp & Dohme LLC | 8 | $178 |
| Janssen Biotech, Inc. | 8 | $169 |
| GlaxoSmithKline, LLC. | 3 | $149 |
| Caris MPI, Inc. | 4 | $147 |
| Stemline Therapeutics Inc. | 2 | $145 |
| Celgene Corporation | 5 | $109 |
| SEAGEN INC. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
Products named: KEYTRUDA, MI CANCER SEEK, Orserdu, OJJAARA, RYBREVANT, XTANDI, REBLOZYL, LYNPARZA.
Industry payments across TX — which companies pay providers there.
